CLINICAL_TRIALS ClinicalTrials.gov record update

Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Cervarix® in Healthy Female Subjects Aged 9 to 14 Years in Mexico

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02979535
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:44.679614+00:00
Published At: 2020-03-09T00:00:00+00:00
Record Updated At: 2022-03-25
Results Posted At: 2020-03-09
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Dengue Fever", "Dengue Hemorrhagic Fever", "Human Papillomavirus Disease"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2022-03-25"
protocolSection.identificationModule.nctId: "NCT02979535"
protocolSection.identificationModule.officialTitle: "Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Cervarix\u00ae in Healthy Female Subjects Aged 9 to 14 Years in Mexico"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2020-03-09"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.